極低温バイアルの市場：容量、材質、無菌性、エンドユーザー別-2025～2030年の世界予測

極低温バイアル市場は、2023年に5億2,516万米ドルと評価され、2024年には5億5,233万米ドルに達すると予測され、CAGR 5.26%で成長し、2030年には7億5,219万米ドルに達すると予測されています。

極低温バイアルは、超低温での生物学的サンプルの保存と保管において極めて重要な役割を果たし、医療、製薬、研究機関、バイオテクノロジー企業などのセクターを支援しています。これらのバイアルは、細胞構造の完全性を維持し、生体分子を長期間保存するために不可欠であり、再生医療、医薬品開発、遺伝子工学にとって極めて重要です。同市場は、凍結保存技術の進歩と相まって、バイオバンキングと個別化医療に対する需要の高まりによって力強い成長を遂げています。製薬研究活動の急増と医療投資の増加が市場をさらに後押ししています。安全性と耐久性を高める改良された材料構成のバイアル、サンプルの追跡を強化するためのスマートラベルの統合、持続可能性の目標を達成するための環境に優しい製品の開発には機会があふれています。推奨事項としては、自動化された保管ソリューションへの投資や、新興市場を開拓するための世界の流通網の強化が挙げられます。しかし、市場に課題がないわけではないです。医療グレードの材料や廃棄物管理プロトコルに関する厳しい規制は、成長を阻害する可能性があります。ロジスティクス、特にコールドチェーンの維持は、依然として複雑でコストのかかる取り組みです。もう一つの限界は、先進的な極低温バイアルに関連するコストが比較的高いことであり、小規模な利害関係者のアクセスを制限する可能性があります。市場の競合情勢から、企業が勢いを維持するためには、絶え間ないイノベーションとコスト効率が必要です。技術革新が必要なセグメントには、IoT対応モニタリングシステムを統合したバイアルの開発、材料の再利用性の向上、極低温システムの拡大性の強化などがあります。優れた耐熱性と使いやすい設計を備えた新規材料に焦点を当てた調査イニシアチブは、極低温貯蔵能力を確実に向上させるために不可欠です。この市場の特徴は、成長の可能性と不安定性が混在していることであり、戦略的な計画と先を見据えた研究開発が、新たな動向を活用し、内在する市場課題を克服する鍵となると考えられます。

市場力学：急速に進化する極低温バイアル市場の主要市場洞察を公開

極低温バイアル市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的意思決定、新たなビジネス機会の獲得を行うことができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • バイオ製薬企業と受託研究機関からの需要の増加
  • バイオバンク需要の急増とバイオテクノロジー産業の成長
  • 新興経済諸国における医療サービスの向上
• 市場抑制要因
  • 極低温バイアルの漏洩に関する問題
• 市場機会
  • 流通における連携とオンライン利用開始
  • 製品のトレーサビリティと信頼性を支える技術の中断
• 市場課題
  • 廃棄問題

ポーターのファイブフォース：極低温バイアル市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォースフレームワークは、企業の競合を評価し、戦略的機会を探るための明確な手法を記載しています。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これら洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：極低温バイアル市場における外部からの影響の把握

外部マクロ環境要因は、極低温バイアル市場の業績力学を形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を記載しています。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析：極低温バイアル市場における競合情勢の把握

極低温バイアル市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、セグメント化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニングマトリックス：極低温バイアル市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、極低温バイアル市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によりベンダーを明確かつ的確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨：極低温バイアル市場における成功への道筋を描く

極低温バイアル市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を検討することで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネス機会を活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目セグメントを網羅した市場の包括的な分析を提供しています。

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力を評価します。

2.市場の開拓度：新興市場における成長機会を特定し、既存セグメントにおける拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを記載しています。

3.市場の多様化：最近の製品発売、未開拓の地域、産業の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発とイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています。

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、地域はどこか？

3.市場を形成する主要技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • バイオ医薬品企業や契約研究機関からの需要増加
    • バイオバンキングの需要の急増とバイオテクノロジー産業の成長
    • 新興経済諸国における医療サービスの改善
  • 抑制要因
    • 極低温バイアルの漏洩に伴う問題
  • 機会
    • 流通における協力とオンラインでの提供開始
    • 製品の追跡可能性と真正性をサポートする技術の中断
  • 課題
    • 廃棄問題
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治
  • 経済
  • 社会
  • 技術
  • 法律
  • 環境

第6章 極低温バイアル市場：容量別

• イントロダクション
• 容量1ml以下
• 容量1ml～3ml
• 容量3ml～5ml
• 容量5ml以上

第7章 極低温バイアル市場：材料別

• イントロダクション
• ポリエチレン
• ポリプロピレン

第8章 極低温バイアルの市場：無菌性別

• イントロダクション
• ガンマ線照射
• 非滅菌
• 滅菌

第9章 極低温バイアル市場：エンドユーザー別

• イントロダクション
• 医薬品メーカー
• 病院・診断センター
• 研究組織

第10章 南北アメリカの極低温バイアルの市場

• イントロダクション
• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第11章 アジア太平洋の極低温バイアルの市場

• イントロダクション
• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第12章 欧州・中東・アフリカの極低温バイアルの市場

• イントロダクション
• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第13章 競合情勢

• 市場シェア分析、2023年
• FPNVポジショニングマトリックス、2023年
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Abdos Labtech Private Limited
• Azer Scientific Inc.
• Biologix Group Ltd.
• Cole-Parmer Instrument Company, LLC
• Corning Incorporated
• Evergreen Sciences, Inc.
• EZ Bio Research LLC
• Sigma-Aldrich Corporation
• Starlab International GmbH
• StemCell Technologies Inc.
• Sumitomo Bakelite Co. Ltd.
• Thermo Fisher Scientific Inc.
• Thomas Scientific, Inc.
• VWR International LLC
• Ziath Ltd.

LIST OF FIGURES

• FIGURE 1. CRYOGENIC VIALS MARKET RESEARCH PROCESS
• FIGURE 2. CRYOGENIC VIALS MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL CRYOGENIC VIALS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY CAPACITY, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY CAPACITY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY MATERIAL, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY MATERIAL, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY STERILITY, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY STERILITY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 13. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. AMERICAS CRYOGENIC VIALS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. AMERICAS CRYOGENIC VIALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. UNITED STATES CRYOGENIC VIALS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 17. UNITED STATES CRYOGENIC VIALS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. ASIA-PACIFIC CRYOGENIC VIALS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. ASIA-PACIFIC CRYOGENIC VIALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. EUROPE, MIDDLE EAST & AFRICA CRYOGENIC VIALS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 21. EUROPE, MIDDLE EAST & AFRICA CRYOGENIC VIALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 22. CRYOGENIC VIALS MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 23. CRYOGENIC VIALS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. CRYOGENIC VIALS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL CRYOGENIC VIALS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. CRYOGENIC VIALS MARKET DYNAMICS
• TABLE 7. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY CAPACITY 1 ML AND BELOW, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY CAPACITY 1ML TO 3 ML, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY CAPACITY 3 ML TO 5 ML, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY CAPACITY 5 ML AND ABOVE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY POLYETHYLENE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY POLYPROPYLENE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY STERILITY, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY GAMMA IRRADIATED, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY NON-STERILE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY STERILE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY DRUG MANUFACTURER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY HOSPITAL & DIAGNOSTIC CENTER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL CRYOGENIC VIALS MARKET SIZE, BY RESEARCH ORGANIZATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. AMERICAS CRYOGENIC VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 24. AMERICAS CRYOGENIC VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 25. AMERICAS CRYOGENIC VIALS MARKET SIZE, BY STERILITY, 2018-2030 (USD MILLION)
• TABLE 26. AMERICAS CRYOGENIC VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 27. AMERICAS CRYOGENIC VIALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 28. ARGENTINA CRYOGENIC VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 29. ARGENTINA CRYOGENIC VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 30. ARGENTINA CRYOGENIC VIALS MARKET SIZE, BY STERILITY, 2018-2030 (USD MILLION)
• TABLE 31. ARGENTINA CRYOGENIC VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 32. BRAZIL CRYOGENIC VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 33. BRAZIL CRYOGENIC VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 34. BRAZIL CRYOGENIC VIALS MARKET SIZE, BY STERILITY, 2018-2030 (USD MILLION)
• TABLE 35. BRAZIL CRYOGENIC VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 36. CANADA CRYOGENIC VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 37. CANADA CRYOGENIC VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 38. CANADA CRYOGENIC VIALS MARKET SIZE, BY STERILITY, 2018-2030 (USD MILLION)
• TABLE 39. CANADA CRYOGENIC VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 40. MEXICO CRYOGENIC VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 41. MEXICO CRYOGENIC VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 42. MEXICO CRYOGENIC VIALS MARKET SIZE, BY STERILITY, 2018-2030 (USD MILLION)
• TABLE 43. MEXICO CRYOGENIC VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 44. UNITED STATES CRYOGENIC VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 45. UNITED STATES CRYOGENIC VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 46. UNITED STATES CRYOGENIC VIALS MARKET SIZE, BY STERILITY, 2018-2030 (USD MILLION)
• TABLE 47. UNITED STATES CRYOGENIC VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 48. UNITED STATES CRYOGENIC VIALS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 49. ASIA-PACIFIC CRYOGENIC VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 50. ASIA-PACIFIC CRYOGENIC VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 51. ASIA-PACIFIC CRYOGENIC VIALS MARKET SIZE, BY STERILITY, 2018-2030 (USD MILLION)
• TABLE 52. ASIA-PACIFIC CRYOGENIC VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 53. ASIA-PACIFIC CRYOGENIC VIALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 54. AUSTRALIA CRYOGENIC VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 55. AUSTRALIA CRYOGENIC VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 56. AUSTRALIA CRYOGENIC VIALS MARKET SIZE, BY STERILITY, 2018-2030 (USD MILLION)
• TABLE 57. AUSTRALIA CRYOGENIC VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 58. CHINA CRYOGENIC VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 59. CHINA CRYOGENIC VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 60. CHINA CRYOGENIC VIALS MARKET SIZE, BY STERILITY, 2018-2030 (USD MILLION)
• TABLE 61. CHINA CRYOGENIC VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 62. INDIA CRYOGENIC VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 63. INDIA CRYOGENIC VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 64. INDIA CRYOGENIC VIALS MARKET SIZE, BY STERILITY, 2018-2030 (USD MILLION)
• TABLE 65. INDIA CRYOGENIC VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 66. INDONESIA CRYOGENIC VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 67. INDONESIA CRYOGENIC VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 68. INDONESIA CRYOGENIC VIALS MARKET SIZE, BY STERILITY, 2018-2030 (USD MILLION)
• TABLE 69. INDONESIA CRYOGENIC VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 70. JAPAN CRYOGENIC VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 71. JAPAN CRYOGENIC VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 72. JAPAN CRYOGENIC VIALS MARKET SIZE, BY STERILITY, 2018-2030 (USD MILLION)
• TABLE 73. JAPAN CRYOGENIC VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 74. MALAYSIA CRYOGENIC VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 75. MALAYSIA CRYOGENIC VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 76. MALAYSIA CRYOGENIC VIALS MARKET SIZE, BY STERILITY, 2018-2030 (USD MILLION)
• TABLE 77. MALAYSIA CRYOGENIC VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 78. PHILIPPINES CRYOGENIC VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 79. PHILIPPINES CRYOGENIC VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 80. PHILIPPINES CRYOGENIC VIALS MARKET SIZE, BY STERILITY, 2018-2030 (USD MILLION)
• TABLE 81. PHILIPPINES CRYOGENIC VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 82. SINGAPORE CRYOGENIC VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 83. SINGAPORE CRYOGENIC VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 84. SINGAPORE CRYOGENIC VIALS MARKET SIZE, BY STERILITY, 2018-2030 (USD MILLION)
• TABLE 85. SINGAPORE CRYOGENIC VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 86. SOUTH KOREA CRYOGENIC VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 87. SOUTH KOREA CRYOGENIC VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 88. SOUTH KOREA CRYOGENIC VIALS MARKET SIZE, BY STERILITY, 2018-2030 (USD MILLION)
• TABLE 89. SOUTH KOREA CRYOGENIC VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 90. TAIWAN CRYOGENIC VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 91. TAIWAN CRYOGENIC VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 92. TAIWAN CRYOGENIC VIALS MARKET SIZE, BY STERILITY, 2018-2030 (USD MILLION)
• TABLE 93. TAIWAN CRYOGENIC VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 94. THAILAND CRYOGENIC VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 95. THAILAND CRYOGENIC VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 96. THAILAND CRYOGENIC VIALS MARKET SIZE, BY STERILITY, 2018-2030 (USD MILLION)
• TABLE 97. THAILAND CRYOGENIC VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 98. VIETNAM CRYOGENIC VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 99. VIETNAM CRYOGENIC VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 100. VIETNAM CRYOGENIC VIALS MARKET SIZE, BY STERILITY, 2018-2030 (USD MILLION)
• TABLE 101. VIETNAM CRYOGENIC VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 102. EUROPE, MIDDLE EAST & AFRICA CRYOGENIC VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 103. EUROPE, MIDDLE EAST & AFRICA CRYOGENIC VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 104. EUROPE, MIDDLE EAST & AFRICA CRYOGENIC VIALS MARKET SIZE, BY STERILITY, 2018-2030 (USD MILLION)
• TABLE 105. EUROPE, MIDDLE EAST & AFRICA CRYOGENIC VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 106. EUROPE, MIDDLE EAST & AFRICA CRYOGENIC VIALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 107. DENMARK CRYOGENIC VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 108. DENMARK CRYOGENIC VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 109. DENMARK CRYOGENIC VIALS MARKET SIZE, BY STERILITY, 2018-2030 (USD MILLION)
• TABLE 110. DENMARK CRYOGENIC VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 111. EGYPT CRYOGENIC VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 112. EGYPT CRYOGENIC VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 113. EGYPT CRYOGENIC VIALS MARKET SIZE, BY STERILITY, 2018-2030 (USD MILLION)
• TABLE 114. EGYPT CRYOGENIC VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 115. FINLAND CRYOGENIC VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 116. FINLAND CRYOGENIC VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 117. FINLAND CRYOGENIC VIALS MARKET SIZE, BY STERILITY, 2018-2030 (USD MILLION)
• TABLE 118. FINLAND CRYOGENIC VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 119. FRANCE CRYOGENIC VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 120. FRANCE CRYOGENIC VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 121. FRANCE CRYOGENIC VIALS MARKET SIZE, BY STERILITY, 2018-2030 (USD MILLION)
• TABLE 122. FRANCE CRYOGENIC VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 123. GERMANY CRYOGENIC VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 124. GERMANY CRYOGENIC VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 125. GERMANY CRYOGENIC VIALS MARKET SIZE, BY STERILITY, 2018-2030 (USD MILLION)
• TABLE 126. GERMANY CRYOGENIC VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 127. ISRAEL CRYOGENIC VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 128. ISRAEL CRYOGENIC VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 129. ISRAEL CRYOGENIC VIALS MARKET SIZE, BY STERILITY, 2018-2030 (USD MILLION)
• TABLE 130. ISRAEL CRYOGENIC VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 131. ITALY CRYOGENIC VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 132. ITALY CRYOGENIC VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 133. ITALY CRYOGENIC VIALS MARKET SIZE, BY STERILITY, 2018-2030 (USD MILLION)
• TABLE 134. ITALY CRYOGENIC VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 135. NETHERLANDS CRYOGENIC VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 136. NETHERLANDS CRYOGENIC VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 137. NETHERLANDS CRYOGENIC VIALS MARKET SIZE, BY STERILITY, 2018-2030 (USD MILLION)
• TABLE 138. NETHERLANDS CRYOGENIC VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 139. NIGERIA CRYOGENIC VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 140. NIGERIA CRYOGENIC VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 141. NIGERIA CRYOGENIC VIALS MARKET SIZE, BY STERILITY, 2018-2030 (USD MILLION)
• TABLE 142. NIGERIA CRYOGENIC VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 143. NORWAY CRYOGENIC VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 144. NORWAY CRYOGENIC VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 145. NORWAY CRYOGENIC VIALS MARKET SIZE, BY STERILITY, 2018-2030 (USD MILLION)
• TABLE 146. NORWAY CRYOGENIC VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 147. POLAND CRYOGENIC VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 148. POLAND CRYOGENIC VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 149. POLAND CRYOGENIC VIALS MARKET SIZE, BY STERILITY, 2018-2030 (USD MILLION)
• TABLE 150. POLAND CRYOGENIC VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 151. QATAR CRYOGENIC VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 152. QATAR CRYOGENIC VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 153. QATAR CRYOGENIC VIALS MARKET SIZE, BY STERILITY, 2018-2030 (USD MILLION)
• TABLE 154. QATAR CRYOGENIC VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 155. RUSSIA CRYOGENIC VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 156. RUSSIA CRYOGENIC VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 157. RUSSIA CRYOGENIC VIALS MARKET SIZE, BY STERILITY, 2018-2030 (USD MILLION)
• TABLE 158. RUSSIA CRYOGENIC VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 159. SAUDI ARABIA CRYOGENIC VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 160. SAUDI ARABIA CRYOGENIC VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 161. SAUDI ARABIA CRYOGENIC VIALS MARKET SIZE, BY STERILITY, 2018-2030 (USD MILLION)
• TABLE 162. SAUDI ARABIA CRYOGENIC VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 163. SOUTH AFRICA CRYOGENIC VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 164. SOUTH AFRICA CRYOGENIC VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 165. SOUTH AFRICA CRYOGENIC VIALS MARKET SIZE, BY STERILITY, 2018-2030 (USD MILLION)
• TABLE 166. SOUTH AFRICA CRYOGENIC VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 167. SPAIN CRYOGENIC VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 168. SPAIN CRYOGENIC VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 169. SPAIN CRYOGENIC VIALS MARKET SIZE, BY STERILITY, 2018-2030 (USD MILLION)
• TABLE 170. SPAIN CRYOGENIC VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 171. SWEDEN CRYOGENIC VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 172. SWEDEN CRYOGENIC VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 173. SWEDEN CRYOGENIC VIALS MARKET SIZE, BY STERILITY, 2018-2030 (USD MILLION)
• TABLE 174. SWEDEN CRYOGENIC VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 175. SWITZERLAND CRYOGENIC VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 176. SWITZERLAND CRYOGENIC VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 177. SWITZERLAND CRYOGENIC VIALS MARKET SIZE, BY STERILITY, 2018-2030 (USD MILLION)
• TABLE 178. SWITZERLAND CRYOGENIC VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 179. TURKEY CRYOGENIC VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 180. TURKEY CRYOGENIC VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 181. TURKEY CRYOGENIC VIALS MARKET SIZE, BY STERILITY, 2018-2030 (USD MILLION)
• TABLE 182. TURKEY CRYOGENIC VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 183. UNITED ARAB EMIRATES CRYOGENIC VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 184. UNITED ARAB EMIRATES CRYOGENIC VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 185. UNITED ARAB EMIRATES CRYOGENIC VIALS MARKET SIZE, BY STERILITY, 2018-2030 (USD MILLION)
• TABLE 186. UNITED ARAB EMIRATES CRYOGENIC VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 187. UNITED KINGDOM CRYOGENIC VIALS MARKET SIZE, BY CAPACITY, 2018-2030 (USD MILLION)
• TABLE 188. UNITED KINGDOM CRYOGENIC VIALS MARKET SIZE, BY MATERIAL, 2018-2030 (USD MILLION)
• TABLE 189. UNITED KINGDOM CRYOGENIC VIALS MARKET SIZE, BY STERILITY, 2018-2030 (USD MILLION)
• TABLE 190. UNITED KINGDOM CRYOGENIC VIALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 191. CRYOGENIC VIALS MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 192. CRYOGENIC VIALS MARKET, FPNV POSITIONING MATRIX, 2023

The Cryogenic Vials Market was valued at USD 525.16 million in 2023, expected to reach USD 552.33 million in 2024, and is projected to grow at a CAGR of 5.26%, to USD 752.19 million by 2030.

Cryogenic vials play a pivotal role in the storage and preservation of biological samples at ultra-low temperatures, aiding sectors like healthcare, pharmaceuticals, research institutions, and biotechnology firms. These vials are indispensable for maintaining the integrity of cellular structures and preserving biomolecules for prolonged periods, making them crucial for regenerative medicine, drug development, and genetic engineering. The market is witnessing robust growth fueled by heightened demand for biobanking and personalized medicine, coupled with advancements in cryopreservation technology. An upsurge in pharmaceutical research activities and increasing healthcare investments further propel the market. Opportunities abound in developing vials with improved material composition that enhance safety and durability, integration of smart labeling for enhanced sample tracking, and eco-friendly products to meet sustainability goals. Recommendations include investing in automated storage solutions and enhancing global distribution networks to tap into emerging markets. However, the market is not without challenges. Stringent regulations concerning medical-grade materials and waste management protocols can impede growth. Logistics, especially the maintenance of the cold chain, remains a complex and costly endeavor. Another limitation is the relatively high cost associated with advanced cryogenic vials, potentially restricting access for smaller stakeholders. The market's competitive landscape necessitates constant innovation and cost efficiency for companies to sustain momentum. Areas ripe for innovation include the development of vials that integrate IoT-enabled monitoring systems, improving the reusability of materials, and enhancing the scalability of cryogenic systems. Research initiatives focusing on novel materials with superior thermal resistance and user-friendly designs are vital to ensuring enhanced cryogenic storage capabilities. The market is characterized by a blend of growth potential and volatility, where strategic planning and forward-thinking research and development will be key to capitalizing on emerging trends and overcoming intrinsic market challenges.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Cryogenic Vials Market

The Cryogenic Vials Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing demand from bio-pharmaceutical companies and contract research organizations
  • Surge in demand for bio-banking and growth in biotechnological industry
  • Improving healthcare services in the developing economies
• Market Restraints
  • Problems associated with leakage of Cryogenic vials
• Market Opportunities
  • Collaboration in distribution and initiated online availability
  • Technology interruptions supporting product traceability and authenticity
• Market Challenges
  • Disposal Issue

Porter's Five Forces: A Strategic Tool for Navigating the Cryogenic Vials Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Cryogenic Vials Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Cryogenic Vials Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Cryogenic Vials Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Cryogenic Vials Market

A detailed market share analysis in the Cryogenic Vials Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Cryogenic Vials Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Cryogenic Vials Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Cryogenic Vials Market

A strategic analysis of the Cryogenic Vials Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Cryogenic Vials Market, highlighting leading vendors and their innovative profiles. These include Abdos Labtech Private Limited, Azer Scientific Inc., Biologix Group Ltd., Cole-Parmer Instrument Company, LLC, Corning Incorporated, Evergreen Sciences, Inc., EZ Bio Research LLC, Sigma-Aldrich Corporation, Starlab International GmbH, StemCell Technologies Inc., Sumitomo Bakelite Co. Ltd., Thermo Fisher Scientific Inc., Thomas Scientific, Inc., VWR International LLC, and Ziath Ltd..

Market Segmentation & Coverage

This research report categorizes the Cryogenic Vials Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Capacity, market is studied across Capacity 1 ml and Below, Capacity 1ml to 3 ml, Capacity 3 ml to 5 ml, and Capacity 5 ml and Above.
• Based on Material, market is studied across Polyethylene and Polypropylene.
• Based on Sterility, market is studied across Gamma Irradiated, Non-Sterile, and Sterile.
• Based on End-User, market is studied across Drug Manufacturer, Hospital & Diagnostic Center, and Research Organization.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing demand from bio-pharmaceutical companies and contract research organizations
    • 5.1.1.2. Surge in demand for bio-banking and growth in biotechnological industry
    • 5.1.1.3. Improving healthcare services in the developing economies
  • 5.1.2. Restraints
    • 5.1.2.1. Problems associated with leakage of Cryogenic vials
  • 5.1.3. Opportunities
    • 5.1.3.1. Collaboration in distribution and initiated online availability
    • 5.1.3.2. Technology interruptions supporting product traceability and authenticity
  • 5.1.4. Challenges
    • 5.1.4.1. Disposal Issue
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Cryogenic Vials Market, by Capacity

• 6.1. Introduction
• 6.2. Capacity 1 ml and Below
• 6.3. Capacity 1ml to 3 ml
• 6.4. Capacity 3 ml to 5 ml
• 6.5. Capacity 5 ml and Above

7. Cryogenic Vials Market, by Material

• 7.1. Introduction
• 7.2. Polyethylene
• 7.3. Polypropylene

8. Cryogenic Vials Market, by Sterility

• 8.1. Introduction
• 8.2. Gamma Irradiated
• 8.3. Non-Sterile
• 8.4. Sterile

9. Cryogenic Vials Market, by End-User

• 9.1. Introduction
• 9.2. Drug Manufacturer
• 9.3. Hospital & Diagnostic Center
• 9.4. Research Organization

10. Americas Cryogenic Vials Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Cryogenic Vials Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Cryogenic Vials Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
• 13.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Abdos Labtech Private Limited
• 2. Azer Scientific Inc.
• 3. Biologix Group Ltd.
• 4. Cole-Parmer Instrument Company, LLC
• 5. Corning Incorporated
• 6. Evergreen Sciences, Inc.
• 7. EZ Bio Research LLC
• 8. Sigma-Aldrich Corporation
• 9. Starlab International GmbH
• 10. StemCell Technologies Inc.
• 11. Sumitomo Bakelite Co. Ltd.
• 12. Thermo Fisher Scientific Inc.
• 13. Thomas Scientific, Inc.
• 14. VWR International LLC
• 15. Ziath Ltd.